Status:
RECRUITING
Kimel Family Centre for Brain Health and Wellness
Lead Sponsor:
Baycrest
Conditions:
Prevention
Dementia
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Participants (n=450; aged 50+; without a diagnosis of dementia; sufficiently fluent in English to complete the assessments and engage in programming) receive a comprehensive dementia risk assessment, ...
Detailed Description
Participants (n=450; aged 50+; without a diagnosis of dementia; sufficiently fluent in English to complete the assessments and engage in programming) complete a baseline assessment consisting of three...
Eligibility Criteria
Inclusion
- Aged 50 years or older
- Sufficiently fluent in English to complete the assessments and participate in programming.
Exclusion
- Diagnosis of dementia.
Key Trial Info
Start Date :
March 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06933667
Start Date
March 26 2024
End Date
August 31 2027
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baycrest
Toronto, Ontario, Canada, M6A 2E1